Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
Local PV and risk management workflows demand near- constant innovation to ensure compliance with health authority requirements. To keep your global company up to date on PV regulatory standards for your local affiliates, it is crucial to implement solutions that increase transparency, efficiency, and standardization, including ICSR management, AI-powered communication agents, local QPPVs, and an RID. of products approved.
To learn more, read this whitepaper.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
Change the model of clinical research by integrating data, expertise, analytics and technology from study design through execution to power better decisions.
Improve the performance of your clinical trials with the power of the IQVIA CORE.
Harness the power of global human expertise combined with automation, artificial intelligence (AI) and machine learning (ML) to design, build and execute end-to-end safety solutions.
Meet the challenge of changing stakeholder demands and increasing cost constraints with IQVIA's integrated technology services and analytics-driven offerings.
Harness the power of automation to execute streamlined end-to-end safety solutions while reducing costs.